Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $14,225,628 | $13,502,965 | $13,296,737 |
| - Cash | $1,255,948 | $1,715,080 | $1,071,288 | $1,180,187 |
| + Debt | $9,335,371 | $11,024,548 | $10,841,350 | $11,004,224 |
| Enterprise Value | – | $23,535,096 | $23,273,027 | $23,120,774 |
| Revenue | $4,884,850 | $4,791,713 | $4,881,454 | $5,084,909 |
| % Growth | 1.9% | -1.8% | -4% | – |
| Gross Profit | $1,242,218 | $1,214,361 | $1,183,978 | $1,270,652 |
| % Margin | 25.4% | 25.3% | 24.3% | 25% |
| EBITDA | $871,482 | $822,370 | $740,731 | $280,970 |
| % Margin | 17.8% | 17.2% | 15.2% | 5.5% |
| Net Income | $274,797 | $225,270 | $151,221 | $66,913 |
| % Margin | 5.6% | 4.7% | 3.1% | 1.3% |
| EPS Diluted | 0.47 | 0.39 | 0.26 | 0.06 |
| % Growth | 20.5% | 50% | 333.3% | – |
| Operating Cash Flow | $741,559 | $774,930 | $162,824 | $831,702 |
| Capital Expenditures | -$192,214 | -$154,383 | -$145,760 | -$240,690 |
| Free Cash Flow | $549,345 | $620,547 | $17,064 | $591,012 |